公司资料
Nuvectis Pharma 股价、新闻与催化剂
- 股票代码:
- NVCT
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
17.76 USD (-3.84%)
收盘价
最后更新: 2026年11月5日
252M USD
市值
股价为何变动
截至 2026年11月5日，NVCT 下跌 3.84%，收于 $17.76。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers. Its development story is centered on precision oncology and smaller, data-sensitive programs.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Nuvectis sits in specialty oncology biotechnology.
商业模式特征
The business depends on proof-of-concept, program prioritization, and the ability to build a differentiated oncology franchise.
生物医药行业定位
Nuvectis is a small-cap oncology catalyst name whose valuation can move sharply on early data.
未来催化剂
- Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story. The market will care about whether either program can show real differentiation.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。